LCTX vs LOW · rev $9.5M vs P/E 18, rev $86.29B
Lineage Cell Therapeutics Inc (LCTX) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
LCTX currently screens at market cap $213.6M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the LCTX and LOW stock pages for the full models.
Not investment advice.